Great Americans: A conversation with Billie Jean King
04:05
Tornado leaves path of devastation in Oklahoma
02:29
Trump says Iran is ‘making an offer’
01:40
Now Playing
FDA moves to fast-track three psychedelic drugs for review
02:00
UP NEXT
Justice Department ends criminal probe of Powell
02:07
Suspect charged in connection with missing graduate students
01:36
Search for suspects after deadly Louisiana mall shooting
01:06
Trump warns U.S. will ‘shoot and kill’ Iranian mine boats
02:25
Wildfires rage in southern Georgia, destroying homes
01:57
Potential mass shooting at New Orleans festival foiled
01:30
Finding common ground in America
01:13
Special forces soldier arrested for placing bets
01:12
Federal government eases regulations on medical marijuana
01:56
Deadly chemical spill in West Virginia
02:00
New baby elephant makes debut at The National Zoo
01:34
Kalshi suspends three politicians from platform
00:52
Massive wildfires explode in Florida and Georgia
01:54
Iran attacks and seizes commercial ships after Trump extends ceasefire
02:22
Terrifying rescue of 7 tourists from cliff in Australia
00:52
Spirit Airlines nears deal with Trump administration
01:04
Nightly News
FDA moves to fast-track three psychedelic drugs for review
NBC News Clone summarizes the latest on: Fda Moves To Fast Track Three Psychedelic Drugs For Review 262086725963 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.
02:00
Copied
A day after the DOJ said it would ease restrictions on medical marijuana, the FDA moves to fast-track some experimental psychedelic drugs for review. They're looking at three drugs for treatment-resistant depression, major depressive disorder, and PTSD. NBC's Anne Thompson reports.April 24, 2026
